[1]
“Intravesical BCG immunotherapy for Non-Muscle Invasive Bladder Cancer during COVID-19 pandemic: Mutual impact and implications”, Chem Biol Lett, vol. 9, no. 2, p. 267, Feb. 2022, Accessed: May 05, 2024. [Online]. Available: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/267